Federal Register of Legislation - Australian Government

Primary content

Other as made
This instrument declares that there is a serious scarcity across Australia of specified medicines containing the active ingredient abatacept, and specifies the substitutable medicines that pharmacists are permitted to dispense in substitution in permitted circumstances.
Administered by: Health
Registered 08 Feb 2022
Tabling HistoryDate
Tabled HR09-Feb-2022
Tabled Senate10-Feb-2022
Date ceased to have effect 30 Jun 2022
Ceased by Self Ceasing
Help with file formats Help with file formats
Legislative Instrument
 
F2022L00121 : Authoritative PDF Document : 0.6MB Primary Document Icon F2022L00121 : ZIP Document : 81KB
10 pages
 

Explanatory Statement
 
F2022L00121ES : PDF Document : 0.5MB Primary Document Icon F2022L00121ES : ZIP Document : 41KB
9 pages